Considerations for routine coagulation monitoring with rivaroxaban: A case report and review of the literature

BACKGROUND: Rivaroxaban is a non-vitamin K antagonist oral anticoagulant that does not require coagulation monitoring based on current recommendations. Our goal is to explore whether routine coagulation monitoring should not be required for all patients receiving oral rivaroxaban, what relationship...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Hai-Di, Cao, Hong-Yan, Song, Zi-Kai, Yang, Shuo, Tang, Ming-Long, Liu, Yang, Qin, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369389/
https://www.ncbi.nlm.nih.gov/pubmed/30746380
http://dx.doi.org/10.12998/wjcc.v7.i3.382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369389/
https://www.ncbi.nlm.nih.gov/pubmed/30746380
http://dx.doi.org/10.12998/wjcc.v7.i3.382

Ejemplares similares